Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.270
+0.310 (7.83%)
At close: Apr 28, 2026, 4:00 PM EDT
4.240
-0.030 (-0.70%)
Pre-market: Apr 29, 2026, 6:41 AM EDT
Achieve Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 227 | 265 | 121 | 87 | 44 | 74 | |
| Market Cap Growth | 200.71% | 118.56% | 38.82% | 98.88% | -40.38% | 51.52% | |
| Enterprise Value | 206 | 226 | 88 | 84 | 41 | 40 | |
| Last Close Price | 4.27 | 4.97 | 3.52 | 4.12 | 2.45 | 7.78 | |
| PB Ratio | 10.56 | 12.30 | 5.79 | -60.22 | 5.28 | 2.62 | |
| P/TBV Ratio | 11.52 | 13.41 | 6.41 | - | 7.49 | 2.90 | |
| Debt / Equity Ratio | 0.70 | 0.70 | 0.48 | -11.55 | 1.95 | 0.54 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.17 | -0.82 | -1.03 | -1.00 | |
| Net Debt / EBITDA Ratio | 0.39 | 0.39 | 0.63 | -0.04 | 0.21 | 0.85 | |
| Net Debt / FCF Ratio | 0.43 | 0.43 | 0.82 | -0.05 | 0.23 | 0.95 | |
| Quick Ratio | 4.01 | 4.01 | 5.14 | 0.75 | 1.15 | 9.49 | |
| Current Ratio | 4.39 | 4.39 | 5.46 | 0.82 | 1.26 | 9.80 | |
| Return on Equity (ROE) | -257.67% | -257.67% | -409.51% | -869.88% | -233.04% | -101.49% | |
| Return on Assets (ROA) | -85.30% | -85.30% | -84.19% | -69.03% | -65.82% | -47.11% | |
| Return on Capital Employed (ROCE) | -167.80% | -167.80% | -122.30% | 1889.70% | -487.30% | -77.00% | |
| Earnings Yield | -24.04% | -20.66% | -32.90% | -34.19% | -96.58% | -45.07% | |
| FCF Yield | -21.76% | -18.70% | -24.59% | -28.09% | -85.68% | -40.03% | |
| Buyback Yield / Dilution | -35.93% | -35.93% | -61.75% | -87.17% | -30.46% | -198.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.